Clinical Trial Update: Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating a four-drug regimen including lopinavir/ritonavir with tenofovir and emtricitabine in antiretroviral-naïve HIV-infected participants …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtriva (emtricitabine)
• Kaletra (lopinavir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Abbott | Conditions: HIV Infections | Phase 3 | Status: COMPLETED